DYADIC INTERNATIONAL INC (DYAI): Nasdaq/NYSE listing notice — Dyadic receives Nasdaq minimum bid price deficiency notice; 180-day cure period through June 17, 2026

DYADIC INTERNATIONAL INC

Received Nasdaq deficiency notice on Dec 19, 2025; bid price below $1 for 30 consecutive business days.
Company has 180 calendar days, until June 17, 2026, to regain compliance by closing at $1+ for 10 consecutive days.
If not compliant by deadline, may qualify for additional 180-day period subject to meeting other listing criteria.
No immediate impact on Nasdaq Capital Market listing; company evaluating options to cure bid price deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

DYADIC INTERNATIONAL INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

December 19, 2025, Dyadic International, Inc. (the “Company”) received a deficiency notice (the “Notice”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the Company’s securities have not maintained the minimum bid price of at least $1 per share required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

DYADIC INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001493152-25-029141

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.